Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this FOA is to support the development and testing of implementation strategies to achieve system-level adoption of evidence-based interventions, guidelines, or practices to improve the delivery, quality, and sustainability of prevention or treatment services for substance use disorders.  

Companion FOA: PAR-21-023 - Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s):  July 19, 2021; November 15, 2021; July 19, 2022; November 15, 2022; July 19, 2023; November 15, 2023.
  • AIDS Application Due Date(s):  July 19, 2021; November 15, 2021; July 19, 2022; November 15, 2022; July 19, 2023; November 15, 2023.

PAR-21-022 Expiration Date New Date November 16, 2021 per issuance of NOT-DA-21-077. (Original Expiration Date: November 16, 2023 )

Agency Website

https://grants.nih.gov/grants/guide/pa-files/PAR-21-022.html

Amount

$2,500,000

Amount Description

Application budgets are limited to $500,000 in direct costs in any project year, and need to reflect the actual needs of the proposed project.

The maximum project period is 5 years.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

November 15, 2021